TriSalus Life Sciences, Inc. TLSI 深 沪
已收盘 02-06 16:00:00 美东时间
4.75
+0.070
+1.50%
华盛通- 最 高4.875
- 今 开4.74
- 成交量 13.12万股
- 最 低 4.605
- 昨 收 4.68
- 总市值 2.37亿
- 52周最高 7.95
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 3.42
- 委 比 -84.21%
- 总股本 4996.43万
- 历史最高 16.24
- 量 比 1.05
- 振 幅 5.77%
- 历史最低 3.32
- 每 手 1
- 风险率 0.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TriSalus Posts $13.2M Q4 Revenue Vs $12.68M Est, $45.2M for 2025 Vs $44.62M Est, Guides $60M–$62M Sales in 2026 Vs $63.77M Est
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) ("TriSalus" or the "Company"), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes
01-12 20:23
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Raises Price Target to $12
Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:TLSI) with a Buy and raises the price target from $11 to $12.
2025-12-18 04:08
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
TriSalus Life Sciences To Present Opinion On TriNav Infusion System, Review Uterine Artery Embolization On Nov. 12
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) ("TriSalus" or the "Company"), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors,
2025-11-10 21:07
TriSalus Life Sciences Grants CFO Stock Options
TriSalus Life Sciences ( ($TLSI) ) has provided an announcement. On August 25, ...
2025-08-30 04:55
TriSalus Life Sciences FY2025 Revenue expected to be more than $44.147M vs $44.837M Est. Revenue for 2025 FY is expected to up by more than 50% YoY from $29.431M.
TriSalus Life Sciences (NASDAQ:TLSI) FY2025 Revenue expected to be more than $44.147M vs $44.837M Est. Revenue for 2025 FY is expected to up by more than 50% YoY from $29.431M
2025-08-13 04:03
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
2025-08-12 16:32
TriSalus Completes Exchange Offer for Preferred Stock
TriSalus Life Sciences ( ($TLSI) ) just unveiled an update. TriSalus Life Scien...
2025-07-25 05:53
TriSalus Launches Exchange Offer for Preferred Stock
TriSalus Life Sciences ( ($TLSI) ) has issued an update. On June 23, 2025, TriS...
2025-06-24 05:47
